Variant report
Variant | nsv527610 |
---|---|
Chromosome Location | chr20:52980099-52984431 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:49347583..49351619-chr20:52982625..52987672,5 | MCF-7 | breast: | |
2 | chr20:52977120..52978918-chr20:52982695..52985421,2 | MCF-7 | breast: | |
3 | chr20:52979804..52981716-chr20:52983200..52985662,2 | MCF-7 | breast: | |
4 | chr20:52981982..52984941-chr20:53255246..53257720,2 | MCF-7 | breast: | |
5 | chr20:52979804..52981716-chr20:52983200..52985662,2 | MCF-7 | breast: | |
6 | chr17:57921876..57923469-chr20:52978562..52980794,2 | MCF-7 | breast: | |
7 | chr20:52982179..52987061-chr20:52989270..52993345,5 | MCF-7 | breast: | |
8 | chr20:52982598..52985363-chr20:52985830..52988598,3 | MCF-7 | breast: | |
9 | chr20:52976917..52979046-chr20:52979757..52981463,2 | MCF-7 | breast: | |
10 | chr20:52983415..52985850-chr6:27858765..27861037,2 | MCF-7 | breast: | |
11 | chr20:42839047..42839970-chr20:52982175..52983148,2 | MCF-7 | breast: | |
12 | chr20:49347789..49349298-chr20:52984375..52987184,2 | MCF-7 | breast: | |
13 | chr20:52979917..52982366-chr20:52988469..52990410,2 | MCF-7 | breast: | |
14 | chr20:52983863..52986994-chr20:52995623..52998239,3 | MCF-7 | breast: | |
15 | chr2:75348194..75350018-chr20:52980164..52981715,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000197153 | chromatin interactions |
ENSG00000132823 | chromatin interactions |
ENSG00000124171 | chromatin interactions |
ENSG00000223891 | chromatin interactions |
ENSG00000233224 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6097942 | chr20:52980099-52980100 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs552283409 | chr20:52980184-52980185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546769886 | chr20:52980185-52980186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566760069 | chr20:52980186-52980187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570862795 | chr20:52980187-52980188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558673693 | chr20:52980189-52980190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138497823 | chr20:52980228-52980229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527795818 | chr20:52980259-52980260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537859349 | chr20:52980357-52980358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs193015003 | chr20:52980362-52980363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573872453 | chr20:52980366-52980367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144094236 | chr20:52980401-52980402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146373709 | chr20:52980428-52980429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553185609 | chr20:52980441-52980442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573113848 | chr20:52980449-52980450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6097943 | chr20:52980461-52980462 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs6064070 | chr20:52980474-52980475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184500709 | chr20:52980523-52980524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564841803 | chr20:52980534-52980535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530493599 | chr20:52980541-52980542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543888950 | chr20:52980550-52980551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561738449 | chr20:52980568-52980569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530314678 | chr20:52980569-52980570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189285103 | chr20:52980577-52980578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530409033 | chr20:52980608-52980609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147336803 | chr20:52980624-52980625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115231735 | chr20:52980626-52980627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148799977 | chr20:52980639-52980640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs386815225 | chr20:52980653-52980654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181983412 | chr20:52980654-52980655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554642797 | chr20:52980662-52980663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114495734 | chr20:52980691-52980692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536539061 | chr20:52980695-52980696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553348937 | chr20:52980730-52980731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1841860 | chr20:52980784-52980785 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs142258238 | chr20:52980787-52980788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs793033 | chr20:52980806-52980807 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs117713386 | chr20:52980855-52980856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544330259 | chr20:52980887-52980888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560713726 | chr20:52981063-52981064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529687893 | chr20:52981080-52981081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550325804 | chr20:52981083-52981084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372636994 | chr20:52981084-52981085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150828452 | chr20:52981106-52981107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372514554 | chr20:52981121-52981122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560422759 | chr20:52981168-52981169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532533636 | chr20:52981172-52981173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183542951 | chr20:52981233-52981234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568588343 | chr20:52981278-52981279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189337605 | chr20:52981292-52981293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 21693616 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Gastric cancer | 20585902 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Cancer | 21129771 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Lung cancer | 16740712 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16620391 | CNVD |
Okamoto syndrome | 17623483 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20459607 | CNVD |
Gastric cancer | 18160780 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:52976600-52983400 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr20:52976600-52985200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr20:52977600-52985200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr20:52977800-52985200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr20:52979200-52984800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr20:52979800-52984600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr20:52980600-52982000 | Enhancers | Liver | Liver |
8 | chr20:52983400-52983600 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr20:52983400-52983800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr20:52983400-52986200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr20:52983600-52984200 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr20:52983800-52985200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr20:52984200-52985000 | Enhancers | H9 Cell Line | embryonic stem cell |